Benjamin Haynor
Stock Analyst at Lake Street
(0.53)
# 3,989
Out of 4,911 analysts
10
Total ratings
33.33%
Success rate
-11.69%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $5.68 | +93.66% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $14.69 | +29.34% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $9.30 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $70 | $0.65 | +10,614.83% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $36.00 | +20.83% | 1 | Jun 27, 2017 |
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $5.68
Upside: +93.66%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $14.69
Upside: +29.34%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.30
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $70
Current: $0.65
Upside: +10,614.83%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $36.00
Upside: +20.83%